U.S. opioid crackdown hampers some patients’ access to psychiatric drugs

Written by on December 12, 2022

WASHINGTON, Dec 12 (Reuters) - A crackdown by U.S. drug wholesalers in response to the opioid crisis is preventing some pharmacists from dispensing a combination of stimulants and sedatives routinely prescribed by psychiatrists to help patients manage conditions like anxiety and ADHD.

The three main U.S. pharmaceutical wholesalers - AmerisourceBergen Corp



Current track

Title

Artist